Carol H. Danielson
Plus aucun poste en cours
Profil
Carol H.
Danielson worked as a Director and Vice President in Regulatory Compliance, Quality Assurance, and Regulatory Affairs for various pharmaceutical companies such as ALZA Corp., Cypress Bioscience, Inc., BioCryst Pharmaceuticals, Inc., and MediQuest Therapeutics, Inc. She also holds an undergraduate degree from Samford University and the University of Delaware, as well as a doctorate from The University of Alabama at Birmingham.
Anciens postes connus de Carol H. Danielson
| Sociétés | Poste | Fin |
|---|---|---|
| COLGATE-PALMOLIVE COMPANY | Conseiller Juridique Général | 01/01/2001 |
| BIOCRYST PHARMACEUTICALS, INC. | Conseiller Juridique Général | 01/01/1999 |
Cypress Bioscience, Inc.
 Cypress Bioscience, Inc. BiotechnologyHealth Technology Cypress Bioscience, Inc. develops drug therapies for Functional Somatic Syndromes, rheumatoid conditions that often cause sufferers chronic pain. The company provides medicine for Fibromyalgia Syndrome, a condition marked by painful stiffness, headaches and fatigue that affects approximately 5% of the world's population. The company was founded in 1981 and is located in San Diego, CA. | Conseiller Juridique Général | 01/01/1993 |
| ALZA CORPORATION | Conseiller Juridique Général | 01/01/1991 |
MediQuest Therapeutics, Inc.
 MediQuest Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology MediQuest Therapeutics, Inc. developed drugs for the treatment of inflammatory skin diseases and conditions. Its lead product candidate, Vascana, is for the prevention and treatment of Raynaud’s Disease and Phenomenon that targets large, underserved markets and utilizes the unique benefits of its TAM delivery technology to address unmet patient needs. The company was founded in 1994 by Dennis E. Schwartz and Lyman Max Lyon Jr. and was headquartered in Seattle, WA. | Conseiller Juridique Général | - |
Formation de Carol H. Danielson
| University of Delaware | Undergraduate Degree |
| The University of Alabama at Birmingham | Doctorate Degree |
| Samford University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| BIOCRYST PHARMACEUTICALS, INC. | Health Technology |
| COLGATE-PALMOLIVE COMPANY | Consumer Non-Durables |
| Entreprise privées | 3 |
|---|---|
Cypress Bioscience, Inc.
Cypress Bioscience, Inc. BiotechnologyHealth Technology Cypress Bioscience, Inc. develops drug therapies for Functional Somatic Syndromes, rheumatoid conditions that often cause sufferers chronic pain. The company provides medicine for Fibromyalgia Syndrome, a condition marked by painful stiffness, headaches and fatigue that affects approximately 5% of the world's population. The company was founded in 1981 and is located in San Diego, CA. | Health Technology |
ALZA Corp.
 ALZA Corp. Pharmaceuticals: MajorHealth Technology ALZA Corp. provides drug delivery solutions and develops pharmaceutical products. The company applies its delivery technologies to develop pharmaceutical products with enhanced therapeutic value for its own portfolio and for many of the world's leading pharmaceutical companies. The company was founded by Martin Gerstel and Alejandro Zaffaroni in 1968 and is headquartered in Vacaville, CA. | Health Technology |
MediQuest Therapeutics, Inc.
MediQuest Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology MediQuest Therapeutics, Inc. developed drugs for the treatment of inflammatory skin diseases and conditions. Its lead product candidate, Vascana, is for the prevention and treatment of Raynaud’s Disease and Phenomenon that targets large, underserved markets and utilizes the unique benefits of its TAM delivery technology to address unmet patient needs. The company was founded in 1994 by Dennis E. Schwartz and Lyman Max Lyon Jr. and was headquartered in Seattle, WA. | Health Technology |
